DCBLD2 anticorps

N° du produit ABIN2423275

Détail du produit anti-DCBLD2 anticorps

Antigène: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp DCBLD2 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogène: Recombinant protein of human DCBLD2

Isotype: IgG

Information d'application

Indications d'application: IHC 1:100-1:300

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Conseil sur la manipulation: Avoid freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur DCBLD2

Antigène: DCBLD2 (Discoidin, CUB and LCCL Domain Containing 2 (DCBLD2))

Autre désignation: DCBLD2 (DCBLD2 Produits)

Synonymes: anticorps DCBLD2, anticorps zgc:158743, anticorps CLCP1, anticorps ESDN, anticorps 1700055P21Rik, anticorps AW146002, anticorps Esdn, anticorps discoidin, CUB and LCCL domain containing 2, anticorps discoidin, CUB and LCCL domain-containing protein 2, anticorps DCBLD2, anticorps dcbld2, anticorps LOC100444682, anticorps Dcbld2

Sujet: CLCP1 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1), also known as DCBLD2 (discoidin, CUB and LCCL domain containing 2) or ESDN, is a 775 amino acid single-pass type I membrane protein that contains one CUB domain, one LCCL domain and one F5/8 type C domain. Expressed at high levels in heart, testis and skeletal muscle, CLCP1 is thought to regulate vascular smooth muscle cell (VSMC) proliferation and remodeling and may be involved in the transformation and metastasis of various cancers, such as metastatic lung cancer and gastric carcinoma.